Member Info for Brighty1

Exactly Billy. This is a smart move by GST. It would be great to see more RNS's announcing additional bitcoin purchases utilising funds from the £2 million placing announced today.......

Good luck, Brighty

Kop, you should read SWC's RNS'. In May of this year when they commenced their own treasury bitcoin plan they purchased just 8.61 Bitcoin as follows, below, and at that stage they owned just 19 bitcoins. Since then the share price has gone from around 3p to approx 500p and they have been able to acquire many more bitcoins over the last few months. The initial purchase details in May 2025 are below. i.e. they started small.....

· Number of Bitcoin Purchased: 8.61 Bitcoin

· Average Purchase Price: £75,460 per Bitcoin ($99,871 per Bitcoin)

· Amount Purchased: £650,000

· Total Bitcoin Holdings: 19.20 Bitcoin

· Total Average Purchase Price: £73,432 per Bitcoin ($97,188 per Bitcoin)

· Total Amount Purchased: £1,410,000

If GST is replicating a similar strategy then we should expect more RNS' announcing further bitcoin purchases using the £2 million. The uplift in the SWC share price of x 140 has been nothing short of incredible on the back of its bitcoin treasury 10 year plan....

Good luck, Brighty

Exactly Enki, people should be paying more attention to what's been happening at SWC and its regular treasury policy of purchasing additional bitcoins. Since they started this policy a few months ago the SWC share price has risen by over X 140. This is a smart move by GST and it would be great to see more RNS's announcing bitcoin purchases with the £2 million raised.......

Good luck, Brighty

Exactly, check out SWC' s share price following its bitcoin treasury reserve strategy. It has soared by over X 140 this year. GST is in the right sector at exactly the right time .....

Good luck, Brighty

Exactly and you'll be looking at much higher than your 2p a share with HE1. More like 10p a share. It's just a matter of time. A X 10 from the current price is very achievable with a few more good RNS updates. We've all seen many X 10 and X 20's over the years. HE1 is on the launch pad now.....

Good luck, Brighty

Exactly and it was a smart move to keep a stake in this to realise its true value over time. There's also news today about the acquisition of a Petrol Filling Station from Sainsbury in Coventry and the redefinition of the Meadow Joint Venture and confirmation (again) that ROAD intends to up its holding in the Meadow JV to 10%. From 3p last year to 50p+ this year, ROAD could be be 70p soon....

Good luck, Brighty

Exactly Maidit308. A x 20 could be on the cards in due course for QBT. For example, ROAD, another of my stocks has risen from 3p to 51p in just over 12 months. Anything is possible. With the right news the QBT share price could soar....

Good luck, Brighty

Exactly. Congratulations to all of us that were buying ROAD at 3p not so long ago. Excellent to see this over 50p. ROAD is certainly one of the best low profile risers of the last year. Still too early for me to offload any with the growth potential here....

Good luck, Brighty

Exactly. Good to see Obelix, Maidit308 and BasilAlderman commenting on the QBT chat. They tend to be under the radar astute investors and names I recognise from the mega SAR gain where we all (presumably) did well. I did a x 30 in my ISA with that one. Good to see you invested in QBT guys. If this comes off it's going to be another X30 multi bagger....

Good luck, Brighty

Exactly and there's also the real possibility of a Trading Update pre the final results.

For example: "GST has had a strong start to the year, with all divisions performing well. Year on year improvements in turnover, profit and cash flow are largely driven by our actions and strategic initiatives. Demand for our products and services also remains strong across the Group. Our full year results for the year ended 31st March 2025 will be released on July 24th".

That would turbo-boost the share price ahead of the results......

Good luck, Brighty

Exactly. A $1 Billion buy out of Helium One in due course is peanuts in this space. It is more than feasible moving forwards. In fact, I would say it is the logical end game here...

Good luck, Brighty

Exactly Muck. A 2million contract win with a leading European biotech company.

Full CDMO service contract covering:

* development

* scale-up

* technical transfer

* manufacture

* & full regulatory approval support....

A few more of these and we are off to 20p plus a share by FY26...

Good luck, Brighty

Exactly and when that happens the share price will be going much much higher. It's just a matter of time. I'm here for 10p+ a share at least. That's a X 10 approx from the current price. It's very achievable with a few more good RNS updates.....

Good luck, Brighty

Exactly. In this sector it's all about "discovery", "feasibility", "development" & "production". That is where the value is created. Many companies on AIM don't make it past "discovery". HE1 fast approaching the final point: "production". That's when value is realised and the share price will then react accordingly. Those that understand this industry know that wealth creation at HE1 is fast approaching for shareholders....

Good luck, Brighty

Exactly, MCNol. If you put a tick next to each of the following you will see how far HE1 is down the line compared to most of the AIM hopefuls.

* Discovery TICK

* Feasibility TICK

* Development TICK

* Production ABOUT TO HAPPEN

HE1 is very close to production at Galactica-Pegasus and that's when the gains will kick in for the share price....

Good luck, Brighty

Exactly. Those that understand this industry comprehend that wealth creation at HE1 is fast approaching. In this sector it's all about "discovery", "feasibility", "development" & "production". HE1 is fast approaching the production element of the cycle. That is where the value is created. Many companies on AIM don't make it past "discovery". HE1 fast approaching the final point: "production". That's when value is realised and the share price will then react accordingly....

Good luck, Brighty

Exactly Enki, I 100% agree. The GST share price rise will be worth the wait. I bought into ROAD 18 months ago at 3p and it's now x 13 at 39p+ today. Patience is all that is required with GST and it will have a similar if not better gain. Having acquired most of my GST shares under 0.5 I'm happy with the progress to date.....

Good luck, Brighty

Exactly. Wealth creation and a much higher share price at HE1 is fast approaching. A re-rate is on the cards soon....

Good luck, Brighty

Exactly. Follow the money as big pharma will pay hundreds of millions (& in some cases billions) for access in to the right product. We have 2: The CYP2C19-ID Stroke Kit and the MT-RNR1 ID Hearing Kit. This is a sector awash with cash and $Billion dollar deals. JP Morgan's latest research (released on 6th May, 2025) and which I posted last week highlighted some very interesting numbers for GDR investors willing to hold out for a deal. Details for those that are interested are below:

* The licensing landscape showed significant shifts in Q1 2025, with biopharma licensing deals reaching $56.8 billion in total announced value, marked by higher upfront payments for later-stage programs. The medtech sector saw 286 licensing partnerships disclosed with $3.7 billion in total value, including $871 million in upfront payments.

* M&A activity showed divergent patterns across sectors in early 2025, with biopharma seeing 27 transactions totaling $25.2 billion, including one large deal surpassing $14 billion. Meanwhile, medtech M&A activity tempered slightly with 57 acquisitions in Q1 totaling $9.2 billion, but still maintained multiyear-high transaction numbers.

Major pharmaceutical companies will be fully aware of GDR's stroke and hearing kits and with the recent update dated May 13th regarding the CYP2C19 kit testing in cardiovascular disease the market opportunities have become much much bigger.....

Good luck, Brighty

Exactly Stephen and Basil. This is a sector awash with cash and $Billion dollar deals. JP Morgan's latest research (6th May, 2025) posted some very interesting numbers for GDR investors willing to hold out for a deal. Details below:

* Biopharma and medtech venture investment continued its strong momentum into 2025, with larger deal sizes.

* The licensing landscape showed significant shifts in Q1 2025, with biopharma licensing deals reaching $56.8 billion in total announced value, marked by higher upfront payments for later-stage programs. The medtech sector saw 286 licensing partnerships disclosed with $3.7 billion in total value, including $871 million in upfront payments.

* M&A activity showed divergent patterns across sectors in early 2025, with biopharma seeing 27 transactions totaling $25.2 billion, including one large deal surpassing $14 billion. Meanwhile, medtech M&A activity tempered slightly with 57 acquisitions in Q1 totaling $9.2 billion, but still maintained multiyear-high transaction numbers.

Follow the money as big pharma will pay hundreds of millions (& in some cases billions) for access in to the right product. GDR is getting closer and closer....

Good luck, Brighty